These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

998 related articles for article (PubMed ID: 30166441)

  • 1. Engineered CRISPR-Cas9 nuclease with expanded targeting space.
    Nishimasu H; Shi X; Ishiguro S; Gao L; Hirano S; Okazaki S; Noda T; Abudayyeh OO; Gootenberg JS; Mori H; Oura S; Holmes B; Tanaka M; Seki M; Hirano H; Aburatani H; Ishitani R; Ikawa M; Yachie N; Zhang F; Nureki O
    Science; 2018 Sep; 361(6408):1259-1262. PubMed ID: 30166441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Basis for the Altered PAM Specificities of Engineered CRISPR-Cas9.
    Hirano S; Nishimasu H; Ishitani R; Nureki O
    Mol Cell; 2016 Mar; 61(6):886-94. PubMed ID: 26990991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Plasticity of PAM Recognition by Engineered Variants of the RNA-Guided Endonuclease Cas9.
    Anders C; Bargsten K; Jinek M
    Mol Cell; 2016 Mar; 61(6):895-902. PubMed ID: 26990992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the scope of CRISPR/Cas9-mediated genome editing in plants using an xCas9 and Cas9-NG hybrid.
    Niu Q; Wu S; Li Y; Yang X; Liu P; Xu Y; Lang Z
    J Integr Plant Biol; 2020 Apr; 62(4):398-402. PubMed ID: 31702097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome editing in plants by engineered CRISPR-Cas9 recognizing NG PAM.
    Endo M; Mikami M; Endo A; Kaya H; Itoh T; Nishimasu H; Nureki O; Toki S
    Nat Plants; 2019 Jan; 5(1):14-17. PubMed ID: 30531939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome Engineering in Rice Using Cas9 Variants that Recognize NG PAM Sequences.
    Hua K; Tao X; Han P; Wang R; Zhu JK
    Mol Plant; 2019 Jul; 12(7):1003-1014. PubMed ID: 30928636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and Engineering of Francisella novicida Cas9.
    Hirano H; Gootenberg JS; Horii T; Abudayyeh OO; Kimura M; Hsu PD; Nakane T; Ishitani R; Hatada I; Zhang F; Nishimasu H; Nureki O
    Cell; 2016 Feb; 164(5):950-61. PubMed ID: 26875867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
    Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
    Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly efficient base editing with expanded targeting scope using SpCas9-NG in rabbits.
    Liu Z; Shan H; Chen S; Chen M; Song Y; Lai L; Li Z
    FASEB J; 2020 Jan; 34(1):588-596. PubMed ID: 31914687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving Plant Genome Editing with High-Fidelity xCas9 and Non-canonical PAM-Targeting Cas9-NG.
    Zhong Z; Sretenovic S; Ren Q; Yang L; Bao Y; Qi C; Yuan M; He Y; Liu S; Liu X; Wang J; Huang L; Wang Y; Baby D; Wang D; Zhang T; Qi Y; Zhang Y
    Mol Plant; 2019 Jul; 12(7):1027-1036. PubMed ID: 30928637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.
    Hu JH; Miller SM; Geurts MH; Tang W; Chen L; Sun N; Zeina CM; Gao X; Rees HA; Lin Z; Liu DR
    Nature; 2018 Apr; 556(7699):57-63. PubMed ID: 29512652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants.
    Walton RT; Christie KA; Whittaker MN; Kleinstiver BP
    Science; 2020 Apr; 368(6488):290-296. PubMed ID: 32217751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cas9-NG Greatly Expands the Targeting Scope of the Genome-Editing Toolkit by Recognizing NG and Other Atypical PAMs in Rice.
    Ren B; Liu L; Li S; Kuang Y; Wang J; Zhang D; Zhou X; Lin H; Zhou H
    Mol Plant; 2019 Jul; 12(7):1015-1026. PubMed ID: 30928635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput analysis of the activities of xCas9, SpCas9-NG and SpCas9 at matched and mismatched target sequences in human cells.
    Kim HK; Lee S; Kim Y; Park J; Min S; Choi JW; Huang TP; Yoon S; Liu DR; Kim HH
    Nat Biomed Eng; 2020 Jan; 4(1):111-124. PubMed ID: 31937939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of genetically modified mice using SpCas9-NG engineered nuclease.
    Fujii W; Ito H; Kanke T; Ikeda A; Sugiura K; Naito K
    Sci Rep; 2019 Sep; 9(1):12878. PubMed ID: 31501500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural insights into a high fidelity variant of SpCas9.
    Guo M; Ren K; Zhu Y; Tang Z; Wang Y; Zhang B; Huang Z
    Cell Res; 2019 Mar; 29(3):183-192. PubMed ID: 30664728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precise CAG repeat contraction in a Huntington's Disease mouse model is enabled by gene editing with SpCas9-NG.
    Oura S; Noda T; Morimura N; Hitoshi S; Nishimasu H; Nagai Y; Nureki O; Ikawa M
    Commun Biol; 2021 Jun; 4(1):771. PubMed ID: 34163001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Basis for the Canonical and Non-canonical PAM Recognition by CRISPR-Cpf1.
    Yamano T; Zetsche B; Ishitani R; Zhang F; Nishimasu H; Nureki O
    Mol Cell; 2017 Aug; 67(4):633-645.e3. PubMed ID: 28781234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly specific targeted mutagenesis in plants using Staphylococcus aureus Cas9.
    Kaya H; Mikami M; Endo A; Endo M; Toki S
    Sci Rep; 2016 May; 6():26871. PubMed ID: 27226350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SpRY greatly expands the genome editing scope in rice with highly flexible PAM recognition.
    Xu Z; Kuang Y; Ren B; Yan D; Yan F; Spetz C; Sun W; Wang G; Zhou X; Zhou H
    Genome Biol; 2021 Jan; 22(1):6. PubMed ID: 33397431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.